The global intracranial stents market was valued at USD 341 million in 2018 and is expected to generate around USD 932 million by 2025, at a CAGR of 15.4 percent between 2019 and 2025. A stroke is a brain attack that occurs by a lack of or reduced blood supply to a part of the brain. It is one of the major causes of intracranial diseases. According to various epidemiological studies, stroke is one of the leading causes of mortality and disability globally. In the U.S. stroke is the third leading cause of death, as over 140,000 people die by stroke annually. 1 in 6 people worldwide will have a stroke in their lifetime. About 15 million people suffer from a stroke annually and about 5.8 million people die from it. Intracranial atherosclerosis contributes to about 8-10 percent of total ischemic strokes. The incidences of intracranial are high in African, Asian, Hispanic Americans, and Latino American populations. The factors responsible for the progression of intracranial diseases are age, hypertension, total serum cholesterol, diabetes mellitus, metabolic syndrome, etc. Certain medical conditions and lifestyle factors speed up the process and increase the risk of having a stroke. Moreover, the augmenting risk of strokes in aging and obese population is anticipated to further drive the global intracranial stents market significantly.
The global intracranial stents market is segmented into product type, disease indication, and end-user. By product type, the global intracranial stents market is segmented into balloon expanding stents, self-expanding stents, and stent-assisted coil embolization. The stent-assisted coil embolization segment held the largest share of the global intracranial stents market in 2018. The stent-assisted coiling is a minimally invasive procedure that offers a non-surgical option to patients with wide neck aneurysms, which wasn’t available before. It comprises placing a stent inside a wide neck aneurysm and protects blood vessel walls from getting damaged. The advanced technology of stent-assisted coil embolization and a growing number of procedures that use it are anticipated to propel this segment in the future. By disease indication, the market is segmented into brain aneurysm and intracranial stenosis. The intracranial stenosis segment held the largest share of the global intracranial stents market during 2018, owing to the high prevalence of atherosclerosis and changing lifestyles of people, such as the growing consumption of junk food.
By end-user, the market is segmented into ambulatory surgery centers, hospitals, and others. Hospitals held the largest share of the global intracranial stents market in 2018. In various categories of hospitals, such as hospital chains, multispecialty hospitals, and small mid-size hospitals, surgeons perform intracranial stenting procedures. Growing investments made by major hospitals in the procurement of branded intracranial stents is the key factor propelling the growth of hospitals globally. By region, North America dominated the global intracranial stents market in 2018 and is anticipated to remain dominant. This can be attributed to the presence of a large geriatric population that is prone to strokes and the high adoption of technically advanced products in the region. The Asia Pacific intracranial stents market is expected to register a high rate of growth in the future, owing to a large base of geriatric population in Japan and intracranial diseases being the second most common cause of death for people above the age of 60.
Some key players of the global intracranial stents market are Acandis, Penumbra, Inc., MicroPort Scientific, Medtronic, Phenox, Stryker Corporation, Boston Scientific Corporation, DePuy Synthes, Cook Medical, and Terumo Corporation, among others. – Zion Market Research